Gram Positive Bacilli

Last updated: November 12, 2024

Bacillus

  • Which gram positive bacilli have vaccines and when are they given
    • Clostridium tetani, Corynebacterium diptheriae
    • Pentavalent vaccine: 6 weeks, 10 weeks, 14 weeks
    • Tetanus Toxoid (TT): pregnant women (1st pregnancy twice 12 weeks, 1 month 2nd – 4th once), women of child bearing age, children at 7-14 years,
  • Which of gram positive bacilli organisms do we give immunoglobulins against
    • Clostridium tetani: IM human tetanus Immunoglobulin (HTIG)
    • Clostridium botulinum: BIG-IV, Bovine (Horse-derived) heptavalent botulism antitoxin
  • What are the general characteristics of Bacillus
    • 60 species
    • Gram positive rods
    • Single or in chains
    • Saprophytic contaminants or normal flora
    • Produce endospores (heat resistance)
    • Aerobic or facultatively anerobic
    • Ubiquitous in soil, water, vegetation, airborne dust
    • Most non-anthracis species are Beta hemolytic, motile and lack the glutamic acid capsule (thus stain negatively with McFadyean’s stain)
    • Species: B. anthracis, B. cereus, B.stearothermophilus, B. circulan, B.megaterium. B.sphaericus. B. licheniformis, B.pumilis, B. subtilits
  • What diseases are associated with the genus Bacillus
    • Anthrax (cutaneous, Gastrointestinal, inhalation)
    • Gastroenteritis (emetic and diarrheal types)
    • Ocular infections
    • Catheter-related sepsis
    • Opportunistic infections
  • What are the laboratory characteristics of Bacillus
    • On Blood Agar (BA):
      • Large, spreading, gray-white colonies with irregular margins
      • Many are beta hemolytic (differentiates the various species of Bacillus from B.anthracis)
    • Most are Catalase positive
    • Spores are seen after several days of incubation, but not typically in fresh clinical specimen
  • What is the historical importance of Bacillus anthracis
    • First pathogenic bacterium to be seen under microscope
    • First bacterium shown to be the cause of a disease (Koch’s postulate)
    • First bacterium to be isolated in pure culture and shown to possess spores
    • First bacterium used for the preparation of attenuated vaccines by Pasteur
  • List the characteristics of Bacillus anthracis
    • Gram positive rods: straight or slightly curved
    • Edge of colony shows irregular comma-shaped outgrowth on blood agar (Medusa head)
    • Bamboo-rod appearance in smears from culture
    • Single, in pairs, and in short chains in smears from infected tissue
    • Capsulated in tissue: Polypeptide capsule with D-glutamate, plasmid mediated
    • Spores forming in vitro: Oval and centrally placed
    • Vegetative cells are destroyed by heat at 60*C for 30 min
    • Spores are resistant to disinfectant and heat and can survive in soil for years
    • Some withstand dry heat at 140C for 1-3 hours and boiling at 100C for 5 – 10 minutes
    • Non-motile
    • Non-acid fast
  • Briefly describe the spores of Bacillus anthracis
    • Soil and mammals are reservoirs – spores can remain viable for decades
    • Highly refractile: resistant to staining, heat, cold, radiation, desiccation and disinfectants
    • Formed in culture or in solid under unfavorable condition – need O2 for sporulation
    • Germinate when exposed to nutrient-rich conditions
      • Tissue/blood of animals and human host
      • Rainfall stimulates spore germination, spread by flies and vultures
    • Conditions that facilitate spore formation
      • Nitrogen and organic soil content
      • environmental pH greater than 6
      • Ambient temperature greater than 6*C
      • 2% sodium chloride
      • Presence of distilled water
      • ***inhibited by compounds such as calcium chloride
    • Spores are never found in host tissue unless the infected body fluids are exposed to ambient air
  • Briefly describe the epidemiology of Bacillus anthracis
    • Primarily a disease of herbivorous animals
    • Humans are rarely infected
    • Transmitted to humans by direct contact with anima products (eg. wool, hair, hide, meat)
    • Also via inhalation and ingestion: increased mortality with these portals of entry
    • Commonly in wild and domestic animals: Asia, Africa, S and Central America, and parts of Europe
    • Still poses a threat
      • Importing material contaminated with spores
      • Usually an occupational disease: veterinarians, agricultural workers
    • Mortality
      • Contact with contaminated animal products (hides, wool, hair): 20% – results in 95% of infections
      • Ingestion of contaminated food products: 95%
      • Inhalation of contaminated dust (Woolsorter’s disease): 95%
  • Briefly describe the transmission of Bacillus anthracis
    • Sick animal or carcasses shed bacilli through orifies (nose, mouth, faeces)
      • Contaminate environment: soil and pastures
    • Infectious agent is mostly the spore
    • Human and other animals acquire the spore
    • Rare in developed countries where routine animal vaccination is done
    • Bioterrorism category A
  • List the virulence factors of Bacillus anthracis
    • Antiphagocytic capsule: plasmid encoded; contains D-glutamate (thus it is a polypeptide capsule)
    • **Anthrax toxin complex (**plasmid encoded)
      • A subunit
        • Edema factor (EF): Binds to calcium and calmodulin and gains AC activity to increase cAMP and cause edema
        • Lethal factor (LF): Zinc metalloprotease that degrades MAPKK leading leading to apoptosis ;also stimulates the release of TNF-a and IL-1 by macrophages
      • B subunit
        • Protective (Antigen): binds to endothelial receptors and facilitates entry of the A subunit into the host cell
      • Edema toxin = PA + EF
      • Lethal toxin = PA + LF
  • List the diseases caused by Bacillus anthracis
    • Cutaneous anthrax: Black eschar
    • Inhalation anthrax (Woolsorter’s disease): Hemorrhagic mediastinitis
    • Gastrointestinal anthrax: Severe bloody diarrhea
  • Describe food poisoning caused by Bacillus cereus
    • Transmission: Bacteria grows in heated food that cools down too slowly or is improperly refrigerated, Reheated rice is a common source of infection
    • Incubation period: Emetic (30min – 6 hours), Diarrheal (6-15 hours)
    • Pathogenesis: Enterotoxin I (preformed cereulide) causes emetic type, Enterotoxin II causes diarrhea
    • Clinical feature: Emetic (nausea and vomiting), Diarrheal (watery diarrhea and abdominal pain)

Clostridium

  • Concerning Clostridiodes difficile, briefly describe the: reservoir, characteristics, epidemiology, and transmission **
    • Reservoir
      • Gastrointestinal tract
    • Characteristics
      • Gram positive rod
      • Obligate anaerobe
      • Spore forming rod
      • Facultative pathogen
    • Epidemiology
      • Present ubiquitously
      • Highly contagious
      • Toxigenic or non-toxigenic; toxigenic strains cause Clostridiodes Difficile Infection (CDI)
    • Transmission
      • Oral route of transmission
        • Community acquired CDI: fecal-oral route
        • Hospital acquired CDI: via contaminated surfaces and medical equipment
  • Briefly describe the Virulence factors and pathogenesis of Clostridium difficile
    • Toxin A (enterotoxin)
      • Active site at N-terminal domain (site of glycosylation)
      • Central hydrophobic domain (required for protein conformational change)
      • Binding site at C-terminal domain (Binds to the target surface)
      • MOA: Binding to brush border of enterocytes → receptor mediated endocytosis → change of conformation → exposure of active domain → glycosylation of target proteins (e.g. Rac, Cdc42, RhoA) → disruption of actin cytoskeletal functioning → increase in epithelial permeability and apoptosis → diarrhea
    • Toxin B (cytotoxin)
      • Binding site at C-terminal domain (binding to oligosaccharides on cell surface)
      • Translocation domain (required for pore formation)
      • Cysteine protease-containing domain
      • Catalytic domain
      • MOA: same as in toxin A, but also causes pore formation within the endosomal membrane via insertion of the translocation domain → release of endosomal content into the cytosol → cytopathic effect
  • Briefly describe Clostridiodes difficile infection (CDI)
    • Asymptomatic colonization (Non-toxigenic CDI)
    • Symptoms develop during antibiotic treatment 2-10 days after initiation
    • 25-40% of cases manifest as late as 10 weeks following treatment
    • Antibiotic associated diarrhoea (C.difficile associated diarrhoea CDAD)
      • Watery-diarrhoes
        • ≥ 3 stools per day associated with characteristic odor
        • May contain traces of mucus or occult blood
        • Hematochezia and melena are both rare
      • Cramping abdominal pain, nausea, anorexia
      • Fever and dehydration
      • Fulminant CDI manifests with abdominal distention and severe hypovolemia (e.g. due to toxic megacolon, paralytic ileus)
    • Pseudomembranous colitis
      • Colonic inflammation results in fibrin exudates, manifesting as pseudomembranes
      • Elevated yellow-white plaques that form pseudomembranes over the colonic mucosa
  • List the laboratory features of Clostridiodes difficile
    • Specimen: stool
    • Stool cytotoxicity neutralization assay (CCNA): detects toxins in stool – distinguishes colonization from active infection
    • ELISA: detects toxins A and B
    • Latex agglutination test – detects presence of glutamate dehydrogenase, produced by C.difficile
    • Stool culture: cannot distinguish colonization (non-toxic strains) from active infection, Robertson-cooked media
    • NAATs: detection of C.difficile genes
  • How is CDI treated
    • D**iscontinue the precipitating antibiotic (**lincosamides are mostly blamed)
    • Antibiotic of choice
      • Metronidazole
      • Oral vancomycin
      • Fidaxomicin
    • Fecal microbiota transpantation may be indicated in recurrent CDI, severe CDI or fulminant CDI refractory to antibiotic therapy
    • Surgical intervention may be necessary for critically ill patients or those with complications necessitating surgery
  • Write short notes on 4 different species in the genus clostridium under the following headings: Reservoir, Characteristics, Virulence Factors, Diseases caused
    • Clostridium difficile
      • Reservoir: Gastrointestinal tract
      • Characteristics: Facultative pathogen
      • Virulence factors: Toxin A (Enterotoxin), Toxin B (Cytotoxin), Adhesin factor, Hyaluronidase, spore formation
      • Diseases: Pseudomembranous colitis, toxic megacolon and antibiotic-associated diarrhea; acute abdomen and fulminant-life threatening colitis (rare), antibiotic associated diarrhea (malaise, anorexia, and mild-moderate diarrhea occasionally with abdominal cramping),
      • Lab features: Specimen (stool), Stool cytotoxin test, ELISA (detect toxins), Latex agglutination test (detect glutamate dehydrogenase), Stool cultures not useful due to non-toxigenic strains, NAAT to detect toxin genes
      • Treatment: Discontinue precipitating antibiotic, oral metronidazole or vancomycin to suppress growth and toxin production, Fecal microbiota transplant
    • Clostridium perfringens
      • Reservoir: Soil, skin, gastrointestinal tract
      • Characteristics: Club-shaped bacilli, Hemolysis double zone on BA
      • Virulence factors: Alpha toxin (Lecithinase), Beta toxin, Epsilon toxin (Permease), Iota toxin, Enterotoxin (Heat-labile), spore formation, aggressins (hyaluronidase, collagenases and proteins that liquefy muscles), bursting factor, neuraminidase
      • Disease: Gas gangrene (Clostridial myonecrosis), food poisoning, simple wound contamination, cellulitis, fasciitis, suppurative myositis
      • Laboratory diagnosis: Specimen (Sloughs of necrotic tissue, exudate from deep area of wound, blood culture in significant septicaemia), Gram smear: GP bacilli predominant and other bacteria with lack of inflammatory cells, Incubation: anerobic, media RCM (rapid growth at 45*C), then on BA after 4-6 hours (double zone of hemolysis, inner – beta hemolysis theta toxin, outer alpha hemolysis alpha toxin), Biochemical test: ferments glucose, lactose, sucrase and maltose, production of acid and gas (H2S and nitrate to nitrite), MR positive, VP negative, indole negative, Stormy fermentation, Nagler reaction: Lecithinase (a-toxin; phospholipase) hydrolized phospholipids in egg-yolk agar around (Egg agar plate half swabbed with serotype antitoxin and dry)
      • Treatment: Wound debridement, penicillin + metronidazole + aminoglycosides or clindamycin + aminoglycosides or broad spectrum antibiotics meropenem or imipenem, Hyperbaric oxygen adjuvant
    • Clostridium tetani
      • Reservoir: Soil
      • Characteristics: Drumstick-shaped, obligate pathogen
      • Virulence factors: Exotoxins: Tenospasmin, Tetanolysin
      • Disease caused: Tetanus
    • Clostridium botulinum
      • Reservoir: Soil, intestinal tracts of birds and fish, agricultural products e.g. vegetables
      • Characteristics: Club-shaped with flagellum
      • Virulence factors: Botulinum toxin
      • Diseases: Foodborne botulism, Infant botulism, Wound botulism
  • Briefly describe the pathogenesis of 2 diseases caused by Clostridium spp.
    • Tetanus:
      • Tetanospasmin reaches CNS via retrograde axonal transport to reach Renshaw cells, Cleaves synaptobrevin (SNARE protein) preventing the release of inhibitory neurotransmitters (GABA and Glycine) from the Renshaw cells
      • This causes uninhibited activation of alpha motor neurons causing spastic paralysis (muscle spasm, rigidity) and autonomic instability
    • Botulism:
      • Botulinum toxin cleaves SNARE proteins, preventing the fusion of transmitter containing vesicles with the presynaptic membrane
      • This inhibits acetylcholine release from the presynaptic axon terminals causing Flaccid paralysis
    • Pseudomembranous colitis:
      • Toxin A (enterotoxin) and Toxin B (cytotoxin) cause actin depolymerization, increased epithelial permeability, apoptosis, diarrhea, and fibrinous exudate that manifests as pseudomembranes
    • Gas gangrene (Clostridial myonecrosis):
      • Lecithinase (a-toxin) degrades phospholipids causing myonecrosis, inhibition of leukocyte function and gas production
  • List the General characteristics of Clostridium perfringens
    • GP rods with blunt ends
    • capsulated
    • non motile
    • spores- large , oval central
    • Nagler reaction- action of its phospholipase on egg yolk medium
    • 5 types based on toxin (A-E)
  • Briefly describe the epidemiology of Clostridium perfringens
    • Type A is commonly found in the GIT of man and animals.
    • Type A is also Widely distributed in nature.
    • It Causes soft tissue infections, food poisoning, necrotizing enteritis, and septicemia
    • Type B-E do not survive in soil but colonize GIT of animals and sometimes, man
  • List the biochemical properties of Clostridium perfringens both saccharolytic and proteolytic
  • List the virulence factors of Clostridium perfringens
    • Spore formation
    • Aggressins (Hyaluronidase, collagenase, proteins that liquefy muscles)
    • Enterotoxin (food contaminating strains)
    • Exotoxins:
      • alpha toxin (Lecithinase): lyses all blood cells and endothelia
      • beta toxin: causes intestinal stasis, loss of mucosa by necrosis and progression to necrotizing enteritis
      • epsilon toxin (permease): activated by trypsin
      • iota toxin: produced by type E. necrotic activity
  • List the clinical diseases caused by Clostridium perfringens
    • Gas gangrene: extensive muscle necrosis, dishwater must odor fluid, crepitations, shock and renal failure. NO INFLAMMATORY CELLS
    • Food poisoning: self limited. Caused by enterotoxin produced by type A
    • Necrotizing enteritis: Commonly of the jejunum. Caused by beta toxin produced by type C
    • Puerperal sepsis
  • List the laboratory features of Clostridium perfringens
    • Specimen- necrotic tissue, deep wound swabs, blood, faces/cont. food
    • Gram smear- GP bacilli with NO inflammatory cells
    • Culture – on Robertson’s Cooked Meat agar then BA
    • Biochemical tests– ferments lactose
    • Nagler reaction
  • How is gas gangrene treated
    • wound debridement
    • high dose antobiotics
    • hyperbaric oxygen- controversial

Compare and contrast the paralysis caused by Clostridium botulinum and Clostridium tetani

TetanusBotulism
ToxinTetanospasmin and tetanolysinBotulinum toxin
MOACleaves SNARE proteins in Renshaw cells to cause unhibited a-motor neuron contractionCleaves SNARE proteins in a-motor neurons to inhibit ACh release
Type of paralysisSpastic paralysisFlaccid paralysis
Other featuresTrismus, Risus sardonicus, opishtotonusFloppy baby syndrome, Xerostomia, Mydriasis, Vomiting
TreatmentAntibiotics and wound debridementIV human botulism immune globulin (BIG-IV)
PreventionIM human tetanus immunoglobulin and Tetanus-containing vaccines (DPT, Tdap, DTap, DT)Boil food twice, avoid exposure

Compare and contrast food poisoning caused by gram-positive spore forming rods

Clostridium perfringensClostridium botulinumBacillus cereus
ToxinHeat-labile Enterotoxin (CPE)Botulinum toxinsCereulide (Enterotoxin I – emetic; Enterotoxin II – non-emetic)
Incubation period8-12 hours12 – 36 hoursEmetic 30 min – 6 hours; Diarrhea 6 – 15 hours
PathogenesisMarked hypersecretionCleaves SNARE proteinsStimulates emesis, Hypersecretion
SymptomsWatery diarrheaConstipation, Nausea, VomitingWatery diarrhea, Nausea, Vomiting
TreatmentSupportiveHorse-derived heptavalent botulism antitoxin; Boil food twice before canningSupportive
  • Describe the principles and associated organisms for: Ascoli’s Thermoprecipitation test, Gel liquefaction, Nagler’s reaction,
    • Ascoli’s thermoprecipitation test:
      • Bacillus anthracis
      • Tissue is ground and boiled for 5 minutes, filtered, and the extract layered over anti-anthrax serum in a narrow tube
      • A ring of precipitate appears at the junction of the 2 liquids within 5 minutes, indicating a positive test
    • Gel liquefaction test
      • Bacillus anthracis
      • Bacillus anthracis liquefies gelatin along and out of the line of inoculation, forming a treelike pattern
    • Nagler’s reaction
      • Clostridium perfringens
      • AKA Lethicinase
      • Performed on egg yolk agar plate. It is half swabbbed with a-toxin antitoxin, and the other half is left dry. The whole plate is streaked with isolated perfringens and incubated for 24-48h.
      • The egg yolk on the dry half of plate is hydrolyzed, while the half with a-toxin antitoxin inhibits hydrolysis

Corynebacterium

  • List the characteristics ofCorynebacteria
    • Gram positive bacilli with swollen ends
    • Associated with leathery pharyngeal membrane (’Korynee’ – club and ‘diptheria’ – leather hide)
    • Exhibit pleomorphism
    • Non-spore forming
    • Non-motile
    • Non-spore forming
    • Irregular staining due to cell wall structure (are gram positive in general though)
    • 46 species of medical importance is Corynebacterium diptheriae
    • Others are collectvely called Diptheroids: C.ulcerans, C.pseudotuberculosis, C.jeikeium
    • Aerobic and facultative anerobes
    • Catalase positive
    • Arranged in: Angled pairs or Parrallel rows/ palisade arrangement (a + b together in one field – chinese alphabet)
      • Due to incomplete separation of daughter cells during dividion when the organism is grown on inadequate media e.g. Loeffler’s coagulated serum
        • Need Biotin to grow
    • Historically cultured on Loeffler’s medium
    • Culturedd on BA or Cysteine-terullite media – Black/grey colonies after 24 – 48 hours
    • Best growth in blood /serum containing medium at 35-37*C with or without CO2 enrichment
    • Irregular shaped, club shaped or V-shaped arrangement
    • Cytoplasmic (Metachromatic, Volutin or Babes Ernst) granules – stain blue, tend to be polar (Albert, Neisser or Ponder stain) – the granules store metabolites (phosphates) required by Corynebacterium – polyphosphate
    • Gram stain easily decolorized especially in older cultures
    • Are resistant to drying, susceptible to heat and regular disinfectants
  • What are the Corynebacterium biotypes based on effects of toxin, clonal morphology and biochemical reactions
    • Gravis (short)
      • Severe effects and clinical features
      • Large, irregular and gray colonies
      • Pleomorphism+
    • Intermedius (short to long)
      • Small, flat and gray colonies
    • Mitis (Long curved bacilli)
      • Causes most disease
      • Small round convex black colonies
      • Pleomorphism ****
    • Belfanti
      • Used mainly for epidemiological classification of isolates
      • Rare
      • Cannot produce exotoxin
  • Briefly describe Diphtheria
    • Acute infectious disease, occurring in epidemics
    • Main group affected are children (Source = nasal carrier or patients) – pattern changing due to vaccines
    • Largest epidemic was in the USSR
    • Transmission: secretions/droplets from URT to URT , rare entry via contact with open sores/clothes, genital tract or eye
    • Initial features confined to URT/Oropharynx – go down to the larynx and trachea
      • Infection of mucous membrane
      • Local invasion and multiplication at the mucosal surface
      • Toxic production at the site
      • Inflammatory response
    • Pharyngitis with pseudomembranes in the throat**:** exudates, EBCs, RBCs, epithelial cells, bacteria, fibrin in the throat
    • Bullneck diptheria (Severe lymphadenopathy): involvement of nasal mucosa and soft palate causing the anterior cervical lymph nodes to enlarge
    • Diphtheric skin lesions is the cutaneous forms of the disease
    • Toxin spread is mediated by tissue destruction via lymphatics and blood vessels (Toxemia)
    • Rare bacteremia to cause septicemia
    • Effects are due to toxins, C. diphtheria does not penetrate into tissues below the mucus membrane
    • Non-toxigenic strains are associated with pharyngitis, cutaneous abscesses
    • Uncommon systemic diseases include endocarditis and osteomyelitis
  • What are the Complications and other toxic effects of Diphtheria
    • Airway obstruction – due to laryngeal involvement
    • Organ involvement – via toxemia
      • Myocardial damage (cardiotoxic) – Main complication (2/3 of patients)
        • Circulatory collapse, heart failure, AV blocks, and dysrhytmias
      • Peripheral nerve degeneration (neurotoxic) – Difficulty swallowing and nasal regurgitation of fluids due to paralysis of palatine and ciliary muscles
      • Visual disturbance, dysphagia, and paralysis of arms/legs resolve spontaneously
      • Damage to adrenal gland, liver, kidney, encephalitis, cerebral infarction, pulmonary embolism
      • Most frequent cause of death is airway obstruction or suffocation following aspiration of the pseudomembrane
  • Briefly describe Cutaneous diphtheria
    • Acquired through skin contact with other infected persons
    • Colonizes skin → entry into subcutaneous tissue through skin breaks
    • Papulae develop first → chronic nonhealing ulcer, sometimes covered with a grayish membrane
    • Systemic toxicity is RARE – usually mixed with staphylococcus and streptococci
    • Common in tropical areas
    • Secondary infection of previous infection or skin abrasion
    • Presents as an ulcer surrounded by erythema and covered with membrane
  • What is the treatment for Diphtheria
    • Specific
      • Administration of Diphteria antitoxin
        • Hyperimmune horse serum even (on patients with a strong clinical background only)
      • IV Penicillin for 14 days OR Erythromycin, azithromycin, or clarithromyin – confirm elimination by nasopharyngeal swab – if positive add 10 days, eradicates organism eliminating toxin source
    • Supportive
      • Airway support
      • Barrier nursing
  • How is Diphtheria prevented and controlled
    • Detection and treatment of carriers and susceptible contacts: Nose + throat swabs, prophylactic antibiotics (single dose of benzylpenicillin or 7 days of erythromycin) and booster vaccination
    • Isolation of infected patients
    • Immunization
      • DPT schedule: 6, 10 and 14 weeks of age (Pentavalent vaccine)
        • One is still able to get infection from non toxigenic strains since diptheria toxoid administration only gives future protection against diptheria causing toxin and not the bacteria
        • Most patients fail to develop protective antibodies after a natural infection

Listeria

  • Concerning Listeria monocytogenes, list the: Mode of transmission, at risk population and the type of food associated with infection
    • Transmission: Ingestion, Contact, Inhalation, Transplacental
    • At risk: Pregnant women, Women (Infertility), Elderly, Immunocompromised, Infants
    • Association: Delicatessen products
  • Describe the Pathogenesis of Listeria monocytogenes
    • Enters the cell via Internalins
    • Survived via Listeriolysin O and Phospholipase C, which pierce the phagolysosome
    • Replicate inside the cytoplasm
    • Direct cell-cell spread via Rocktet tail (Express of ActA) – Allows Listeria to spreads without exposure to humoral immunity (antibodies and component)
    • Entry into macrophages marks disseminated disease
  • List the diseases caused by Listeria monocytogenes and their specific demographic
    • Neonatal Listeriosis: Granulomatosis infantiseptica, Meningitis, Meningoencephalitis
    • Infection in pregnant women: Spontaneous abortion
    • Healthy adults: Mild gastroenteritis ****
    • Immunocompromised adults: Meningitis
  • Briefly describe the laboratory features of Listeria monocytogenes
    • Specimen: CSF, blood and amniotic fluid, Cervical and high vaginal swabs, Neonatal meconium, Placenta, biopsies of granulomas
    • Gram stain: GP short coccobacilli often confused with diptheroid, sometimes found in chains
    • Tumbling motility at 25C immotile at 37C (differential motility due to temperature dependent flagella expression)
    • Culture: conventional non-selective media and selective PALCAM
      • BA: small grey, translucent, drop like colonies surrounded by a narrow zone of β-hemolysis
      • Clear tryptose agar (Mueller Hinton Agar – MHA): pale blue-green colonies when viewed from side with a beam of white light
      • Growth improves at refrigeration temperatures (cold enrichment) – delicatessen (deli) products are usually stored at 4*C
    • Biochemical reactions: Ferments fructose and maltose with acid production, Catalase positive, Indole negative, Oxidase negative, Urease negative, Positive CAMP test
  • What are the characteristics of Listeria monocytogenes
    • Gram positive coccobacilli appearing singly, in pairs or in short chains
    • Opportunistic pathogens – immunocompromised and pregnant women
    • Non-capsulated
    • Non-spore forming
    • Aerobic and facultative anaerobe
    • Facultative intracellular bacteria
    • Capable of growth at broad temp range (1C-45C) and high concentration of salt
    • Capable of growth at low pH
    • Beta hemolysis on BA
    • Catalase positive* – GBS is catalase negative
    • Tumbling motility (flagellar) – GBS is not motile
    • CAMP positive (Block type CAMP test reaction) – GBS more arrowhead
  • How is Listeriosis treated
    • Ampicillin
    • Cotrimoxazole
    • Cephalosporin resistance
  • How is Listeriosis prevented
    • Thorough cooking of food
    • Washing fresh vegetables
    • Avoid consumption of unpasteurized daily products
    • No vaccines
    • Prophylactic antibiotic

Gardnerella

  • What are the characteristics of Gardnerella vaginalis
    • Gram variable rod
    • Facultative anaerobe
    • Gram positive cell wall
    • Normal vaginal flora – considered a dysbyosis when vaginal Lactobacilli decrease
    • Catalase negative
  • Name the disease caused by Gardnerella vaginalis and give a short description
    • Bacterial Vaginosis
      • Abnormal vaginal flora (Low concentration of Lactobacillus acidosis) promotes the proliferation and overgrowth of Gardnerella vaginalis and other anaerobes. There is no vaginal inflammation
      • Features: gray or milky vaginal discharge with a fishy odor
      • Diagnosis
        • Wet preparation of a vaginal mount shows Clue cells
        • Positive Whiff test
        • Vaginal pH > 4.5

Erysipelothrix rhusiopathiae

  • What are the characteristics of Erysipelothrix rhusiopathiae
    • Gram positive
    • None-spore forming
    • Slender rods
    • Hair-like filaments
    • Microaerophilic
    • No motility – distinguished from listeria
    • Catalase negative
    • Produce H2S
    • Human diseases is zoonotic and occupational (butchers, meat processors, farmers, poultry workers, fish handlers, vets)
    • Cutaneous infection: SC inoculation via abrasion or puncture wound while handling contaminated animal products or soil
    • Incidence of human disease – unknown, not reportable
    • On tonsils of GIT of many wild and domestic animals (mammals, birds, fish)
    • High in swine and turkey
    • Can survive in soil for months to year
    • Resistant to high concentrations of salt, pickling and smoking
  • What are the clinical diseases caused by Erysipeloxis
    • Erysipeloid
      • Not to be confused with streptococcal erysipelas
      • Violaceous lesion with raised edge: 2 to 7 days after trauma, on finger or hands
      • Spreads peripherally as central discolourization fades
      • Painful, pruritic – burning or throbbing sensation
      • Suppuration is uncommon (Important distinction from a streptococcal infection)
    • Generalized cutaneous disease
    • Septicaemia: endocarditis, osteomyelitis, meningitis , arthritis, lymphopharyngitis, lymphadenitis
  • Describe the laboratory diagnosis of Erysipeloid
    • Sample: Deep aspirate or full-thickness biopsy specimens
    • Gram stain: typically negative, presence of thin gram positive rods associated with characteristic lesion and clinical history is diagnostic
    • Growth on most conventional lab media in 5% to 10% CO2 (Slow-growth read of 3 to more days)
    • Absence of motility and catalase production distinguished from Listeria
    • Produces H2S on TSI
    • Catalase negative
    • Oxidase negative
    • Indole negative (Distinguishes it from Enterobacteriaceae)
    • Vogues-Proskauer negative (Distinguishes it from Enterobacteriaceae)
    • Methyl red negative (Distinguishes it from Enterobacteriaceae)
    • Serology not useful
    • Produces black colonies on terullite agar like corynebacteria
    • convex translucent colonies surrounded by a variable zone of alpha hemolysis
    • Positive gram stain with hair-like filament production
  • How is Erysipeloid treated, prevented and controlled
    • Penicillin
    • Cephalosporin, Carbapenems, fluoroquinolones and clindamycin
    • Use of gloves and other protective equipment for workers

Cutibacterium

  • Describe the sites, group of patients, pathogenesis, clinical features, and treatment ofCutibacterium acnes infection
    • Formerly propionibacterium
    • Sites found: skin, conjunctiva, external ear, oropharynx, female genital tract
    • Common patients: teenagers and yound adults
    • Clinical diseases: acne vulgaris, endodontic abscesses, lacrimal canaliculitis
    • Pathogenesis: Stimulates local inflammatory reaction: production of Low Molecular Weight peptides in sebacious follicles → neutrophil infiltration → phagocytosis → release of bacterial hydrolytic enzymes
    • Culture: Grown on common media (2-5 days for colonies), contaminates blood cultures
    • Treatment: acne unreleated to skin cleansing (lesions within sebaceous follicles), managed by topical application of benzoyl peroxide, antibiotics (erythromycin, clindamycin)
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *